[Retracted] Circular RNA circFAT1(e2) Facilitates Cell Progression through the miR-30e-5P/MYBL2 Pathway in Glioma

Figure 3

MYBL2 expressions in different glioma histologies and their relation with various clinical features. (a) MYBL2 expression differences in different histologies. The abscissa is the histology, and the ordinate is the gene expression of MYBL2. (b) MYBL2 expression differences in different WHO grades. The expression level of MYBL2 increased with the increase in grade. (c) MYBL2 expression differences in IDH mutation status. The expression level of MYBL2 in the wild type was higher than that in the mutant type. (d) MYBL2 expression differences in 1p/19q codeletion status. The expression level of MYBL2 in noncodel was higher than that in codel. (e) The expression differences of MYBL2 in age status. The expression level of MYBL2 in patients older than 42 years was higher than that in patients younger than 42 years. (f) MYBL2 expression differences in gender. There was no significant difference in the expression level of MYBL2 in patients of different genders.

(a)

(b)

(c)

(d)

(e)

(f)